TPCK

CAT:
804-HY-124379-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
TPCK - image 1

TPCK

  • Description:

    TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK) is an effective serine protease inhibitor and also a blocker of the PDK1/Akt pathway. TPCK can modify the E7 protein in actively keratinocyte cells. TPCK can induce cellular apoptosis, suppress tumor growth, reduce hypoxic-ischemic brain injury in rat pups, and affect vascular permeability in inflamed rats[1][2][3][4][5].
  • Product Name Alternative:

    L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK
  • UNSPSC:

    12352005
  • Hazard Statement:

    H315, H318, H335
  • Target:

    Apoptosis; HPV; PDK-1; Ser/Thr Protease
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection; Apoptosis; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Infection; Inflammation/Immunology; Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/tpck.html
  • Purity:

    99.0
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    CC1=CC=C (C=C1) S (N[C@@H] (CC2=CC=CC=C2) C (CCl) =O) (=O) =O
  • Molecular Formula:

    C17H18ClNO3S
  • Molecular Weight:

    351.85
  • Precautions:

    H315, H318, H335
  • References & Citations:

    [1]H Stöppler, et al. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. Virology. 1996 Mar 15;217 (2) :542-53.|[2]Patrícia de A Machado, et al. Effects of a Serine Protease Inhibitor N- p-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on Leishmania amazonensis and Leishmania infantum. Pharmaceutics.2022 Jun 29;14 (7) :1373.|[3]H Stöppler, et al. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. Virology. 1996 Mar 15;217 (2) :542-53.|[4]M H LeBlanc, et al. N-tosyl-L-phenylalanyl-chloromethylketone reduces hypoxic-ischemic brain injury in rat pups. Eur J Pharmacol. 2000 Mar 3;390 (3) :249-56|[5]K Watanabe, et al. Vascular permeability changes by proteinase inhibitors in carrageenin-induced inflammation in rats. Agents Actions. 1986 Mar;17 (5-6) :472-7.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • CAS Number:

    402-71-1